The store will not work correctly when cookies are disabled.
4-cyclohexyl-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-1,2,3-triazole
ID: ALA397813
PubChem CID: 44434482
Max Phase: Preclinical
Molecular Formula: C15H14Cl2F3N3
Molecular Weight: 364.20
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: FC(F)(F)c1cc(Cl)c(-n2cc(C3CCCCC3)nn2)c(Cl)c1
Standard InChI: InChI=1S/C15H14Cl2F3N3/c16-11-6-10(15(18,19)20)7-12(17)14(11)23-8-13(21-22-23)9-4-2-1-3-5-9/h6-9H,1-5H2
Standard InChI Key: GVROTPJHPVHTKV-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
-0.5818 -5.6606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2032 -5.4070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2065 -4.5819 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.5800 -4.3245 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0632 -4.9921 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.8882 -4.9911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2963 -4.2763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1206 -4.2750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5347 -4.9895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1187 -5.7068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2958 -5.7047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.3597 -4.9896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1917 -5.0264 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-4.3780 -4.1648 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-4.3333 -5.8142 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-1.8807 -6.4176 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-1.8815 -3.5632 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
0.8693 -5.8938 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7761 -6.7121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4381 -7.1984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1947 -6.8687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2853 -6.0477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6193 -5.5564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11 6 1 0
1 2 2 0
9 12 1 0
5 6 1 0
12 13 1 0
12 14 1 0
6 7 2 0
12 15 1 0
2 3 1 0
11 16 1 0
7 8 1 0
7 17 1 0
3 4 2 0
2 18 1 0
18 19 1 0
8 9 2 0
4 5 1 0
9 10 1 0
5 1 1 0
10 11 2 0
18 23 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 364.20 | Molecular Weight (Monoisotopic): 363.0517 | AlogP: 5.64 | #Rotatable Bonds: 2 |
Polar Surface Area: 30.71 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 0.15 | CX LogP: 6.01 | CX LogD: 6.01 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.69 | Np Likeness Score: -1.40 |
References
1. Alam MS, Huang J, Ozoe F, Matsumura F, Ozoe Y.. (2007) Synthesis, 3D-QSAR, and docking studies of 1-phenyl-1H-1,2,3-triazoles as selective antagonists for beta3 over alpha1beta2gamma2 GABA receptors., 15 (15): [PMID:17544280] [10.1016/j.bmc.2007.05.039] |